Ghasem Noorkhajavi | Leadership Development | Best Researcher Award

Dr. Ghasem Noorkhajavi | Leadership Development | Best Researcher Award

Researcher | The University of  Tabriz Medical Sciences | Iran

Ghasem Noorkhajavi is an accomplished researcher whose scientific contributions span the interdisciplinary fields of nanomedicine, cancer immunotherapy, and biomedical nanotechnology. His research primarily focuses on developing and optimizing nanostructured systems for targeted drug delivery, immunogenic cell death induction, and exosome-mediated cancer therapy. With a growing academic influence reflected in 6 research documents, 93 citations, and an h-index of 6, his scholarly work demonstrates both depth and innovation in translational nanomedicine. His studies have explored the immunotherapeutic mechanisms of icilin and menthol-loaded nanoparticles, emphasizing their role in triggering  and enhancing antitumor immune responses. Through the design of icilin-based nanostructures and nanolipid carriers, he has contributed to understanding how nanoscale systems can modulate cancer cell signaling and immune activation. His research also extends to the synthesis of quantum dots and carbon nanomaterials with applications in bioimaging, drug delivery, and cancer detection. Beyond oncology, his investigations encompass postbiotics and their potential applications in detoxification, antimicrobial defense, and as adjuvants in viral therapy. Notable works include studies on aflatoxin biodetoxification, pesticide mitigation, and postbiotics for SARS-CoV-2 disease therapy, which highlight his multidisciplinary approach bridging nanotechnology, microbiology, and biomedical engineering. His publications in reputed journals such as Nanomedicine, Cancer Cell International, Journal of Biological Engineering, and Probiotics and Antimicrobial Proteins reflect both academic rigor and translational potential. Through his innovative focus on nanostructured systems and biological interactions, his research contributes significantly to advancing therapeutic nanotechnology, particularly in the context of precision oncology and regenerative medicine. Ghasem Noorkhajavi’s scholarly profile embodies a balance of scientific curiosity, technological innovation, and commitment to improving human health through the integration of nanoscience and biomedical research.

Featured Publications

Khani, N., Abedi Soleimani, R., Noorkhajavi, G., Abedi Soleimani, A., Abbasi, A. Postbiotics as potential promising tools for disease adjuvant therapy. Journal of Applied Microbiology.

Khani, N., Noorkhajavi, G., Soleiman, R. A., Raziabad, R. H., Rad, A. H.Aflatoxin biodetoxification strategies based on postbiotics. Probiotics and Antimicrobial Proteins.

Khani, N., Noorkhajavi, G., Reziabad, R. H., Rad, A. H., & Ziavand, M. Postbiotics as potential detoxification tools for mitigation of pesticides. Probiotics and Antimicrobial Proteins.

Esmaeili, A., Soleimani, M., Rouhani, M., Noorkhajavi, G., Aghaei-Zarch, S. M. Xenograft-based skin substitutes: A critical review. Journal of Drug Delivery Science and Technology.

Panahizadeh, R., Panahi, P., Asghariazar, V., Makaremi, S., Noorkhajavi, G. A literature review of recent advances in gastric cancer treatment: Exploring the cross-talk between targeted therapies. Cancer Cell International.